沒(méi)有藥典USP40-NF35中“硫代甘油”的質(zhì)量標(biāo)準(zhǔn)pdf版   [更多]

藥智網(wǎng)建有一個(gè)中標(biāo)數(shù)據(jù)庫(kù)http://db.yaozh.com/yaopinzhongbiao.html收集了全國(guó)各省市的藥品中標(biāo)信息，為了保證給大家有更準(zhǔn)確及時(shí)的信息，需要對(duì)藥品中標(biāo)信息數(shù)據(jù)庫(kù)及時(shí)更新，現(xiàn)請(qǐng)人進(jìn)行最新中標(biāo)數(shù)據(jù)的收集整理。 工作內(nèi)容：及時(shí)查到最新公布的藥品中標(biāo)信息，并將最新的文件按指定要求處理成規(guī)范的格式(excel表)。 不是一次性任務(wù)。長(zhǎng)期合作(一年以上)   [更多]

需求文獻(xiàn)： 1、DAWSON PA， KARPEN SJ． Bile acids reach out to the spinal cord： new insights to the pathogenesis of itch and analgesia in cholestatic liver disease ［J］． Hepatology， 2014， 59 （4）：1638－1641． 2、Kremer AE, van Dijk R, Leckie P, et al. Serum autotaxin is increased in pruirtus of cholestasis, but not of other oirgin, and responds to therapeutic interventions[J]. Hepatology, 2012(56): 1391-1400. 3、Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis. Sumeyye Samur,Matthew Klebanoff,Reiner Banken,Daniel S. Pratt. 《Hepatology》 , 2017 , 65 (3) :920. 4、Obeticholic acid for PBC. Hugh Thomas. Nature Reviews Gastroenterology & Hepatology 13, 558-559 (2016). 5、Emerging and future therapies for nonalcoholic steatohepatitis in adults. Gesthimani Mintziori , Stergios A. Polyzos. 《Expert Opinion on Pharmacotherapy》 , 2016 , 17 (14) :1 -10. 6、9、Obeticholic acid for the treatment of primary biliary cirrhosis. Trivedi PJ, Hirschfield GM, Gershwin ME. Expert Rev Clin Pharmacol. 2016;9(1):13-26. doi:10.1586/17512433.2015.1092381. Epub 2015 Nov 7. 7、Kowdley K，Nevens F，Andreone P，et al． The first new trials for primary biliary cirrhosis in a decade: an international program evaluating the farnesoid X receptor agonist obeticholic acid［J］． Gastroenterology，2015，1481 ( 4) : S991-S992． 8、Treatment of Non-Alcoholic Fatty Liver Disease . Scherer A., Dufour J.-F. 9、Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers. Pencek R, Marmon T, Roth JD, Liberman A, Hooshmand-Rad R, Young MA. Diabetes Obes Metab. 2016 Sep;18 (9):936-40. doi: 10.1111/dom.12681. Epub 2016 Jun 6. 10、Metabolite profiling of CHO?cells with different growth characteristic 11、Sun, Zhaoyun; Peng, Xinhua; Dong, Xiongzi; Shi, Wenwen - Asian Journal of Chemistry, 2012, vol. 24, # 2, p. 929 - 930 要求：下載符合需求的文獻(xiàn)PDF格式打包上傳   [更多]

文獻(xiàn)名稱： 1、 A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids。British journal of Dermatology. Volume 157, Issue 5 November 2007 Pages 954-959 2、Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: Results from 3 randomized, comparative studies. JAAD. May 2005Volume 52, Issue 5, Pages 810-822 3、Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors. BJD Volume 165, Issue 3 September 2011 Pages 465-473 4、 Comparative Effectiveness of Topical Calcineurin Inhibitors in Adult Patients with Atopic Dermatitis . American Journal of Clinical Dermatology.April 2012, Volume 13, Issue 2, pp 113-123 5、Alikani M, Fauser BCJ, García-Valesco JA, Simpson JL, Johnson MH. Response from the Editors: first birth following spindle transfer. Reprod Biomed Online. 2017 Jul 20. pii: S1472-6483(17)30308-5. doi: 10.1016/j.rbmo.2017.07.002. [Epub ahead of print] PubMed PMID: 28781009. 6、Alikani M, Fauser BCJ, García-Valesco JA, Simpson JL, Johnson MH. First birth following spindle transfer for mitochondrial replacement therapy: hope and trepidation. Reprod Biomed Online. 2017 Apr;34(4):333-336. doi: 10.1016/j.rbmo.2017.02.004. PubMed PMID: 28385333. 7、 Simpson JL. Reproducing genetics. Genet Med. 2015 Jun;17(6):512-4. doi: 10.1038/gim.2015.37. PubMed PMID: 26035802. 8、Wou K, Feinberg JL, Wapner RJ, Simpson JL. Cell-free DNA versus intact fetal cells for prenatal genetic diagnostics: what does the future hold? Expert Rev Mol Diagn. 2015;15(8):989-98. doi: 10.1586/14737159.2015.1051529. Epub 2015 May 31. Review. PubMed PMID: 26027684. 9、Zhao S, Li G, Dalgleish R, Vujovic S, Jiao X, Li J, Simpson JL, Qin Y, Ivanisevic M, Ivovic M, Tancic M, Al-Azzawi F, Chen ZJ. Transcription factor SOHLH1 potentially associated with   [更多]

文獻(xiàn)名稱: 1、 Premedication with?Intravenous Ibuprofen?Improves Recovery Characteristics and Stress Response in Adults Undergoing Laparoscopic Cholecystectomy: A Randomized Controlled Trial. Le V, Kurnutala L, SchianodiCola J, Ahmed K, Yarmush J, Daniel Eloy J, Shapiro M, Haile M, Bekker A. Pain Med. 2016 Feb 18. pii: pnv113. [Epub ahead of print] 2、 A multicenter, randomized, double-blind placebo-controlled, single dose trial of the safety and efficacy of?intravenous ibuprofen?for treatment of pain in pediatric patients undergoing tonsillectomy. Moss JR, Watcha MF, Bendel LP, McCarthy DL, Witham SL, Glover CD. Paediatr Anaesth. 2014 May;24(5):483-9. doi: 10.1111/pan.12381. Epub 2014 Mar 20. 3、 Early?intravenous ibuprofen?decreases narcotic requirement and length of stay after traumatic rib fracture. Bayouth L, Safcsak K, Cheatham ML, Smith CP, Birrer KL, Promes JT. Am Surg. 2013 Nov;79(11):1207-12. 4、 Impact of oral versus?intravenous ibuprofen?on neurodevelopmental outcome: a randomized controlled parallel study. 5、 Ahn BO, Dong HK, Cho H, Kang KK, Park BS, Na KH, et al. Four-week Repeated Dose Toxicity Study of Recombinant Human Basic Fibroblast Growth Factor by Subcutaneous Administration in Rats. Toxicological Research. 1999;15. 6、 Dong HK, Cho H, Kang KK, Ahn BO, Kim WB. Acute Toxicity Study on Recombinant Human Basic Fibroblast Growth Factor in Rats and Dogs. Toxicological Research. 1999;15. 7、 Meduri A, Aragona P, Grenga PL, Roszkowska AM. Effect of basic fibroblast growth factor on corneal epithelial healing after photorefractive keratectomy. Journal of refractive surgery (Thorofare, NJ : 1995). 2012;28(3):220-3. Eras Z, Gokmen T, Erdeve O, Ozyurt BM, Saridas B, Dilmen U. Am J Perinatol. 2013 Nov;30(10):857-62. doi: 10.1055/s-0033-1333667. Epub 2013 Jan 28. 8、 Intravenous ibuprofen?for postoperative pain. Kroll PB. Pain Manag. 2012 Jan;2(1):47-54. doi: 10.2217/pmt.11.68. 9、 A multicenter, randomized, double-blind,   [更多]

具體要求; 需要英國(guó)藥典標(biāo)準(zhǔn)“Appendix XII B. Monographs of the British Pharmacopoeia”《 BP2017 》的藥典標(biāo)準(zhǔn)一份.   [更多]

求DOF（Drugs of the future）2017年第6、7兩期的文章（共17篇） 地址如下： https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_journal_home_pr?p_JournalID=2&p_VolumeID=42   [更多]

要求：1.熟悉圖片去水印方法。 2.處理完225張圖片上面的水印標(biāo)記，提交后待檢查效果達(dá)到要求后才判為合格，否則為不合格任務(wù)。 3.需處理的圖片待接下任務(wù)后再提供。   [更多]

文獻(xiàn)名稱: 1.Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia. Am. J. Hematol. 2009, 84:422–427 2.15:05:49 憨出出 2017/10/11 15:05:49 EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis 3.Japan Guideline for treatment of chronic heart failure(JCS 2010) 備注: 將符合要求的文獻(xiàn)PDF格式打包上傳   [更多]

要求： 1. 熟悉PDF編輯技巧(去水印、去章印、增刪內(nèi)容) 2. 處理完221個(gè)PDF上面的水印標(biāo)記和部分與文章標(biāo)題無(wú)關(guān)的內(nèi)容，提交后待成品效果符合要求后才判為合格，否則為不合格任務(wù)（具體處理細(xì)則可以QQ咨詢） 3. 需處理的PDFE文檔待接下任務(wù)后再提供   [更多]